Design Therapeutics, Inc. (DSGN)
NASDAQ·Healthcare·Biotechnology
$11.81
+10.26%
Mkt Cap $685.15M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$17.50
Range $14.00 – $21.00
Implied Upside
+48.2%
Consensus $17.50 vs current $11.81
NASDAQ·Healthcare·Biotechnology
$11.81
+10.26%
Mkt Cap $685.15M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$17.50
Range $14.00 – $21.00
+48.2%
Consensus $17.50 vs current $11.81